ARCAD Fundamental Analysis - ARCADIS NV

Fundamental Rating

Taking everything into account, ARCAD scores 5 out of 10 in our fundamental rating. ARCAD was compared to 34 industry peers in the Professional Services industry. ARCAD scores excellent on profitability, but there are some minor concerns on its financial health. ARCAD has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ARCAD had positive earnings in the past year.
ARCAD had a positive operating cash flow in the past year.
Each year in the past 5 years ARCAD has been profitable.
In the past 5 years ARCAD always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 6.17%, ARCAD is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
ARCAD has a better Return On Equity (22.00%) than 67.65% of its industry peers.
ARCAD's Return On Invested Capital of 10.90% is fine compared to the rest of the industry. ARCAD outperforms 70.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARCAD is in line with the industry average of 11.54%.
The last Return On Invested Capital (10.90%) for ARCAD is above the 3 year average (9.74%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	6.17%
ROE	22%
ROIC	10.91%

ROA(3y)4.63%

ROA(5y)4.14%

ROE(3y)15.99%

ROE(5y)13.31%

ROIC(3y)9.74%

ROIC(5y)9.75%

1.3 Margins

Looking at the Profit Margin, with a value of 6.17%, ARCAD is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
In the last couple of years the Profit Margin of ARCAD has grown nicely.
ARCAD has a better Operating Margin (9.64%) than 67.65% of its industry peers.
In the last couple of years the Operating Margin of ARCAD has grown nicely.

		Industry Rank	Sector Rank
OM	9.64%
PM (TTM)	6.17%
GM	N/A

OM growth 3Y5.13%

OM growth 5Y8.46%

PM growth 3Y-1.46%

PM growth 5Y67.33%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ARCAD is still creating some value.
ARCAD has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ARCAD has more shares outstanding
ARCAD has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.53 indicates that ARCAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.53, ARCAD is in line with its industry, outperforming 47.06% of the companies in the same industry.
The Debt to FCF ratio of ARCAD is 5.46, which is a neutral value as it means it would take ARCAD, 5.46 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.46, ARCAD is in line with its industry, outperforming 50.00% of the companies in the same industry.
ARCAD has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.12, ARCAD perfoms like the industry average, outperforming 44.12% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.12
Debt/FCF	5.46
Altman-Z	2.53

ROIC/WACC1.71

WACC6.39%

2.3 Liquidity

A Current Ratio of 1.27 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD's Current ratio of 1.27 is fine compared to the rest of the industry. ARCAD outperforms 70.59% of its industry peers.
A Quick Ratio of 1.27 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD has a better Quick ratio (1.27) than 73.53% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.27
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EPS 1Y (TTM)N/A

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-2.7%

3.2 Future

ARCAD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.28% yearly.
ARCAD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.52% yearly.

EPS Next Y9.71%

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

EPS Next 5Y-5.28%

Revenue Next Year1.48%

Revenue Next 2Y15.79%

Revenue Next 3Y8.76%

Revenue Next 5Y4.52%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.42, the valuation of ARCAD can be described as rather expensive.
67.65% of the companies in the same industry are more expensive than ARCAD, based on the Price/Earnings ratio.
ARCAD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.54.
A Price/Forward Earnings ratio of 21.88 indicates a rather expensive valuation of ARCAD.
ARCAD's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ARCAD is more expensive than 64.71% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ARCAD to the average of the S&P500 Index (24.31), we can say ARCAD is valued inline with the index average.

		Industry Rank	Sector Rank
PE	24.42
Fwd PE	21.88

4.2 Price Multiples

ARCAD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ARCAD is cheaper than 70.59% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ARCAD is valued a bit cheaper than 73.53% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	13.49
EV/EBITDA	8.6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ARCAD has a very decent profitability rating, which may justify a higher PE ratio.
ARCAD's earnings are expected to decrease with -7.26% in the coming years. This may justify a cheaper valuation.

PEG (NY)2.52

PEG (5Y)N/A

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 2.75%.
The stock price of ARCAD dropped by -21.94% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 2.44, ARCAD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, ARCAD pays a bit more dividend than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	2.75%

5.2 History

On average, the dividend of ARCAD grows each year by 31.53%, which is quite nice.

Dividend Growth(5Y)31.53%

Div Incr Years6

Div Non Decr Years6

5.3 Sustainability

ARCAD pays out 37.39% of its income as dividend. This is a sustainable payout ratio.

DP37.39%

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ARCADIS NV

AMS:ARCAD (1/16/2026, 11:14:19 AM)

37.6

-0.18 (-0.48%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryProfessional Services

Earnings (Last)10-30 2025-10-30

Earnings (Next)02-19 2026-02-19

Inst Owners58.87%

Inst Owner ChangeN/A

Ins Owners0.46%

Ins Owner ChangeN/A

Market Cap3.40B

Revenue(TTM)1.89B

Net Income(TTM)238.00M

Analysts80

Price Target59.93 (59.39%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.75%

Yearly Dividend0.85

Dividend Growth(5Y)31.53%

DP37.39%

Div Incr Years6

Div Non Decr Years6

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-25.48%

Min EPS beat(2)-36.09%

Max EPS beat(2)-14.86%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-30.78%

Min Revenue beat(2)-35.5%

Max Revenue beat(2)-26.05%

Revenue beat(4)0

Avg Revenue beat(4)-17.6%

Min Revenue beat(4)-35.5%

Max Revenue beat(4)-4.39%

Revenue beat(8)0

Avg Revenue beat(8)-15.75%

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-1.08%

EPS NQ rev (1m)0%

EPS NQ rev (3m)5.88%

EPS NY rev (1m)-0.08%

EPS NY rev (3m)-5.48%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-22.22%

Revenue NY rev (1m)-2.17%

Revenue NY rev (3m)-9.76%

Valuation

		Industry Rank	Sector Rank
PE	24.42
Fwd PE	21.88
P/S	0.88
P/FCF	13.49
P/OCF	11.77
P/B	3.14
P/tB	N/A
EV/EBITDA	8.6

EPS(TTM)1.54

EY4.1%

EPS(NY)1.72

Fwd EY4.57%

FCF(TTM)2.79

FCFY7.41%

OCF(TTM)3.2

OCFY8.5%

SpS42.66

BVpS11.96

TBVpS-4.58

PEG (NY)2.52

PEG (5Y)N/A

Graham Number20.36

Profitability

		Industry Rank	Sector Rank
ROA	6.17%
ROE	22%
ROCE	15.97%
ROIC	10.91%
ROICexc	12.52%
ROICexgc	42.24%
OM	9.64%
PM (TTM)	6.17%
GM	N/A
FCFM	6.53%

ROA(3y)4.63%

ROA(5y)4.14%

ROE(3y)15.99%

ROE(5y)13.31%

ROIC(3y)9.74%

ROIC(5y)9.75%

ROICexc(3y)11.24%

ROICexc(5y)11.87%

ROICexgc(3y)46.91%

ROICexgc(5y)45.96%

ROCE(3y)13.66%

ROCE(5y)13.67%

ROICexgc growth 3Y8.93%

ROICexgc growth 5Y-10.74%

ROICexc growth 3Y2.55%

ROICexc growth 5Y6.48%

OM growth 3Y5.13%

OM growth 5Y8.46%

PM growth 3Y-1.46%

PM growth 5Y67.33%

GM growth 3YN/A

GM growth 5YN/A

F-Score7

Asset Turnover1

Health

		Industry Rank	Sector Rank
Debt/Equity	1.12
Debt/FCF	5.46
Debt/EBITDA	2.4
Cap/Depr	27.21%
Cap/Sales	0.96%
Interest Coverage	8.65
Cash Conversion	56.89%
Profit Quality	105.88%
Current Ratio	1.27
Quick Ratio	1.27
Altman-Z	2.53

F-Score7

WACC6.39%

ROIC/WACC1.71

Cap/Depr(3y)29.56%

Cap/Depr(5y)27.6%

Cap/Sales(3y)1.19%

Cap/Sales(5y)1.19%

Profit Quality(3y)159.52%

Profit Quality(5y)558.67%

High Growth Momentum

Growth

EPS 1Y (TTM)N/A

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y9.71%

EPS Next 2Y5.64%

EPS Next 3Y-7.26%

EPS Next 5Y-5.28%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-2.7%

Revenue Next Year1.48%

Revenue Next 2Y15.79%

Revenue Next 3Y8.76%

Revenue Next 5Y4.52%

EBIT growth 1Y14.27%

EBIT growth 3Y20.69%

EBIT growth 5Y17.72%

EBIT Next Year33%

EBIT Next 3Y16.66%

EBIT Next 5Y11.52%

FCF growth 1Y103.03%

FCF growth 3Y1.15%

FCF growth 5Y12.49%

OCF growth 1Y72.3%

OCF growth 3Y2.04%

OCF growth 5Y9.96%

ARCADIS NV / ARCAD.AS FAQ

Can you provide the ChartMill fundamental rating for ARCADIS NV?

ChartMill assigns a fundamental rating of 5 / 10 to ARCAD.AS.

What is the valuation status for ARCAD stock?

ChartMill assigns a valuation rating of 3 / 10 to ARCADIS NV (ARCAD.AS). This can be considered as Overvalued.

Can you provide the profitability details for ARCADIS NV?

ARCADIS NV (ARCAD.AS) has a profitability rating of 7 / 10.

What are the PE and PB ratios of ARCADIS NV (ARCAD.AS) stock?

The Price/Earnings (PE) ratio for ARCADIS NV (ARCAD.AS) is 24.42 and the Price/Book (PB) ratio is 3.14.

What is the financial health of ARCADIS NV (ARCAD.AS) stock?

The financial health rating of ARCADIS NV (ARCAD.AS) is 5 / 10.

ARCADIS NV (ARCAD.AS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

ARCADIS NV / ARCAD.AS FAQ

Can you provide the ChartMill fundamental rating for ARCADIS NV?

What is the valuation status for ARCAD stock?

Can you provide the profitability details for ARCADIS NV?

What are the PE and PB ratios of ARCADIS NV (ARCAD.AS) stock?

What is the financial health of ARCADIS NV (ARCAD.AS) stock?